TickerFacts.

GT Biopharma, Inc. (GTBP) — Operating Cash Flow

Annual figures by period end, from SEC filings.

2010-12-31: -$1.53M2011-12-31: -$963.0K2012-12-31: -$987.0K2013-12-31: -$442.0K2014-12-31: -$1.75M2015-12-31: -$4.66M2016-12-31: -$1.93M2017-12-31: -$5.43M2018-12-31: -$10.68M2019-12-31: -$3.66M2020-12-31: -$7.26M2021-12-31: -$15.61M2022-12-31: -$15.22M2023-12-31: -$8.85M2024-12-31: -$12.90M2025-12-31: -$12.91M-$12.91M
2010-12-31Operating Cash Flow (USD)2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$12.91M—2026-03-02From 2025-01-01
2024-12-31-$12.90M—2026-03-02From 2024-01-01
2023-12-31-$8.85M—2025-02-21From 2023-01-01
2022-12-31-$15.22M—2024-03-26From 2022-01-01
2021-12-31-$15.61M—2023-03-30From 2021-01-01
2020-12-31-$7.26M—2022-03-28From 2020-01-01
2019-12-31-$3.66M—2021-04-16From 2019-01-01
2018-12-31-$10.68M—2020-03-27From 2018-01-01
2017-12-31-$5.43M—2019-03-29From 2017-01-01
2016-12-31-$1.93M—2018-03-01From 2016-01-01
2015-12-31-$4.66M—2018-02-28From 2015-01-01
2014-12-31-$1.75M—2018-02-28From 2014-01-01
2013-12-31-$442.0K—2015-03-31From 2013-01-01
2012-12-31-$987.0K—2015-01-08From 2012-01-01
2011-12-31-$963.0K—2014-11-18From 2011-01-01
2010-12-31-$1.53M—2012-04-16From 2010-01-01